Tag - VPH

Markets

Echelon starts Valeo Pharma at speculative buy; PT $1 (Canadian)

Echelon Capital Markets initiated coverage of Valeo Pharma (TSX:VPH) with a “speculative buy” rating and price target of $1 (Canadian). The stock closed at 55 cents on March 8. Valeo commercializes de-risked, innovative...

March 9, 2023

Markets

Research Capital ups Valeo Pharma PT on new drug licensing

Research Capital raised its price target for Valeo Pharma (CSE:VPH) to $1 (Canadian) from 70 cents and maintained a “speculative buy” rating after the company closed a $40-million (U.S.) non-dilutive financing from...

August 2, 2022

Tag - VPH

Echelon starts Valeo Pharma at speculative buy; PT $1 (Canadian)

Research Capital ups Valeo Pharma PT on new drug licensing

General

More